{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/galmed-announces-first-time-results-in-prostate-oncology-studies-aramchol-demonstrates-3-4-fold-increase-in-cell-death-compared-to-enzalutamide-xtandi-alone-in-prostate-cancer-models-302852805.html", "message": "News view counter 886864 successfully enlarged"}